NEWLINK GENETICS CORP (40)
Browse by Contract Category
Contracts
-
Form of Indemnity Agreement by and between the Registrant and its directors and officers
(Filed With SEC on March 11, 2022)
-
Employment Agreement, dated August 3, 2021, by and between the Registrant and Dr. David Karp
(Filed With SEC on November 5, 2021)
-
Asset Purchase Agreement by and among Lumos Pharma, Inc., Ammonett Pharma LLC, and each of certain individuals listed therein, dated as of July 26, 2018
(Filed With SEC on June 1, 2020)
-
License Agreement by and between Merck Sharp & Dohme Corp. and Ammonett Pharma LLC, effective as of October 22, 2013
(Filed With SEC on June 1, 2020)
-
Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated November 19, 2019, by and among NewLink Genetics Corporation, Cyclone Merger Sub, Inc. and Lumos Pharma,...
(Filed With SEC on November 20, 2019)
-
Amendment to License and Collaboration Agreement dated
(Filed With SEC on March 5, 2019)
-
Description of Securities
(Filed With SEC on March 11, 2022)
-
Amendment No. 1, dated August 4, 2021, to Employment Agreement by and between the Registrant and John McKew
(Filed With SEC on August 6, 2021)
-
Amendment No. 1, dated June 30, 2021, to Employment Agreement by and between the Registrant and Lori Lawley
(Filed With SEC on August 6, 2021)
-
Form of Indemnity Agreement by and between the Registrant and its directors and officers
(Filed With SEC on March 9, 2021)
-
Description of Securities
(Filed With SEC on March 9, 2021)
-
Controlled Equity Offering
(Filed With SEC on December 30, 2020)
-
PRV Transfer Agreement, dated as of July 27, 2020, by and between the Registrant and Merck, Sharp & Dohme Corp
(Filed With SEC on August 14, 2020)
-
Amendment No. 1 as of August 12, 2020 to Lumos Merck Agreement with Merck
(Filed With SEC on August 14, 2020)
-
Employment Agreement, dated as of March 27, 2020, by and between the Registrant and John McKew
(Filed With SEC on April 2, 2020)
-
Employment Agreement, dated as of March 27, 2020, by and between the Registrant and Richard Hawkins
(Filed With SEC on April 2, 2020)
-
Lumos Pharma, Inc. 2012 Equity Incentive Plan
(Filed With SEC on March 18, 2020)
-
2016 Form of Stock Option Grant Notice
(Filed With SEC on March 18, 2020)
-
Lumos Pharma, Inc. 2016 Stock Plan
(Filed With SEC on March 18, 2020)
-
2012 Equity Incentive Plan Form of Incentive Stock Option Grant Notice
(Filed With SEC on March 18, 2020)
-
Form of Common Stock Certificate
(Filed With SEC on March 18, 2020)
-
Description of Securities
(Filed With SEC on March 3, 2020)
-
Separation Agreement by and between the Registrant and Charles J. Link, Jr. dated August 3, 2019
(Filed With SEC on November 6, 2019)
-
Agreement and Plan of Merger and Reorganization, dated September 30, 2019, by and among NewLink Genetics Corporation, Cyclone Merger Sub, Inc. and Lumos Pharma, Inc
(Filed With SEC on September 30, 2019)
-
Form of Support Agreement, by and between NewLink Genetics Corporation and its directors and officers and by and between NewLink Genetics Corporation and Stine Seed Farm, Inc
(Filed With SEC on September 30, 2019)
-
Transition Agreement, by and between NewLink Genetics Corporation and Nicholas Vahanian, dated September 27, 2019
(Filed With SEC on September 30, 2019)
-
Form of Lock-Up Agreement
(Filed With SEC on September 30, 2019)
-
Employment Agreement, by and between NewLink Genetics Corporation and Carl Langren, dated September 30, 2019
(Filed With SEC on September 30, 2019)
-
Employment Agreement, by and between NewLink Genetics Corporation and Eugene Kennedy, dated September 30, 2019
(Filed With SEC on September 30, 2019)
-
Employment Agreement, by and between NewLink Genetics Corporation and Brad Powers, dated September 30, 2019
(Filed With SEC on September 30, 2019)
-
Employment Agreement, by and between NewLink Genetics Corporation and Lori Lawley, dated September 30, 2019
(Filed With SEC on September 30, 2019)
-
Amended and Restated 2009 Equity Incentive Plan
(Filed With SEC on August 8, 2019)
-
Amendment to License Agreement dated July 10, 2014 by and between the Registrant and Medical College of Georgia Research Institute, Inc
(Filed With SEC on May 8, 2019)
-
Amendment dated March 28, 2006 to the License Agreement by and between the Company and Georgia Regents Research Institute, Inc., formerly known as Medical College of Georgia...
(Filed With SEC on May 8, 2019)
-
Amendment to License Agreement dated February 13, 2007 by and between the Registrant and Medical College of Georgia Research Institute, Inc
(Filed With SEC on May 8, 2019)
-
Amendment to License Agreement dated April 27, 2006 by and between the Registrant and Medical College of Georgia Research Institute, Inc
(Filed With SEC on May 8, 2019)
-
Amendment to License Agreement dated April 27, 2006 by and between the Registrant and Medical College of Georgia Research Institute, Inc
(Filed With SEC on May 8, 2019)
-
License Agreement dated September 13, 2005 by and between the Registrant and Medical College of Georgia Research Institute, Inc
(Filed With SEC on May 8, 2019)
-
Amendment to the
(Filed With SEC on March 5, 2019)
-
2019 Equity Awards
(Filed With SEC on March 5, 2019)